Analytical methods for the retrieval and interpretation of continuous glucose monitoring data in diabetes
- PMID: 19216923
- DOI: 10.1016/S0076-6879(08)03803-2
Analytical methods for the retrieval and interpretation of continuous glucose monitoring data in diabetes
Abstract
Scientific and industrial effort is now increasingly focused on the development of closed-loop control systems (artificial pancreas) to control glucose metabolism of people with diabetes, particularly type 1 diabetes mellitus. The primary prerequisite to a successful artificial pancreas, and to optimal diabetes control in general, is the continuous glucose monitor (CGM), which measures glucose levels frequently (e.g., every 5 min). Thus, a CGM collects detailed glucose time series, which carry significant information about the dynamics of glucose fluctuations. However, a CGM assesses blood glucose indirectly via subcutaneous determinations. As a result, two types of analytical problems arise for the retrieval and interpretation of CGM data: (1) the order and the timing of CGM readings and (2) sensor errors, time lag, and deviations from BG need to be accounted for. In order to improve the quality of information extracted from CGM data, we suggest several analytical and data visualization methods. These analyses evaluate CGM errors, assess risks associated with glucose variability, quantify glucose system stability, and predict glucose fluctuation. All analyses are illustrated with data collected using MiniMed CGMS (Medtronic, Northridge, CA) and Freestyle Navigator (Abbott Diabetes Care, Alameda, CA). It is important to remember that traditional statistics do not work well with CGM data because consecutive CGM readings are highly interdependent. In conclusion, advanced analysis and visualization of CGM data allow for evaluation of dynamical characteristics of diabetes and reveal clinical information that is inaccessible via standard statistics, which do not take into account the temporal structure of data. The use of such methods has the potential to enable optimal glycemic control in diabetes and, in the future, artificial pancreas systems.
Similar articles
-
Time lag characterization of two continuous glucose monitoring systems.Diabetes Res Clin Pract. 2010 Mar;87(3):348-53. doi: 10.1016/j.diabres.2009.11.014. Diabetes Res Clin Pract. 2010. PMID: 20022127 Clinical Trial.
-
Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application.Diabetes Technol Ther. 2005 Dec;7(6):849-62. doi: 10.1089/dia.2005.7.849. Diabetes Technol Ther. 2005. PMID: 16386091
-
Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology.J Diabetes Sci Technol. 2008 Jan;2(1):158-63. doi: 10.1177/193229680800200125. J Diabetes Sci Technol. 2008. PMID: 19578532 Free PMC article.
-
Continuous glucose monitoring in type 2 diabetes.Diabetes Res Clin Pract. 2008 Dec 15;82 Suppl 2:S118-21. doi: 10.1016/j.diabres.2008.09.051. Epub 2008 Nov 22. Diabetes Res Clin Pract. 2008. PMID: 19027978 Review.
-
Continuous glucose monitoring: an overview of today's technologies and their clinical applications.Int J Clin Pract Suppl. 2002 Jul;(129):75-9. Int J Clin Pract Suppl. 2002. PMID: 12166611 Review.
Cited by
-
Reduction of measurement noise in a continuous glucose monitor by coating the sensor with a zwitterionic polymer.Nat Biomed Eng. 2018 Dec;2(12):894-906. doi: 10.1038/s41551-018-0273-3. Epub 2018 Jul 30. Nat Biomed Eng. 2018. PMID: 30931173 Free PMC article.
-
Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?J Diabetes Sci Technol. 2015 Aug 14;10(1):50-9. doi: 10.1177/1932296815599177. J Diabetes Sci Technol. 2015. PMID: 26275643 Free PMC article.
-
Statistical Packages and Algorithms for the Analysis of Continuous Glucose Monitoring Data: A Systematic Review.J Diabetes Sci Technol. 2025 May;19(3):787-809. doi: 10.1177/19322968231221803. Epub 2024 Jan 5. J Diabetes Sci Technol. 2025. PMID: 38179940 Free PMC article.
-
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes.Diabetes Ther. 2020 Jun;11(6):1293-1302. doi: 10.1007/s13300-020-00808-y. Epub 2020 Apr 17. Diabetes Ther. 2020. PMID: 32304086 Free PMC article.
-
Extremum Seeking Control for Personalized Zone Adaptation in Model Predictive Control for Type 1 Diabetes.IEEE Trans Biomed Eng. 2018 Aug;65(8):1859-1870. doi: 10.1109/TBME.2017.2783238. Epub 2017 Dec 13. IEEE Trans Biomed Eng. 2018. PMID: 29989925 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials